Insider Transactions in Q3 2021 at Alaunos Therapeutics, Inc. (TCRT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2021
|
Jaime Vieser |
BUY
Open market or private purchase
|
Direct |
100,000
+12.42%
|
$100,000
$1.91 P/Share
|
|
Sep 02
2021
|
Robert W Postma |
BUY
Open market or private purchase
|
Indirect |
54,492
+1.27%
|
$54,492
$1.73 P/Share
|
|
Sep 02
2021
|
Robert W Postma |
BUY
Open market or private purchase
|
Direct |
20,508
+1.68%
|
$20,508
$1.73 P/Share
|
|
Sep 02
2021
|
Heidi Hagen Director |
BUY
Open market or private purchase
|
Direct |
23,770
+14.01%
|
$23,770
$1.76 P/Share
|
|
Sep 01
2021
|
James Huang Director |
BUY
Open market or private purchase
|
Direct |
100,000
+48.0%
|
$100,000
$1.71 P/Share
|
|
Sep 01
2021
|
Holger Weis |
BUY
Open market or private purchase
|
Direct |
50,000
+29.38%
|
$50,000
$1.83 P/Share
|
|
Aug 30
2021
|
Kevin S. Boyle Sr. Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
875,000
+50.0%
|
-
|